• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    98.73 Down 0.69(0.69%) Feb 27, 4:00PM EST
    |After Hours : 98.72 Down 0.01 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 13,374   14,954   2,099  
    Cost of Revenue -   -   -  
    Gross Profit 13,374   14,954   2,099  
    Operating Expenses
    Research Development79,644  37,347  17,346  
    Selling General and Administrative27,560  17,396  9,268  
    Non Recurring -   -   -  
    Others2,073  3,232  504  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (95,903) (43,021) (25,019)
    Income from Continuing Operations
    Total Other Income/Expenses Net159   -  (259)
    Earnings Before Interest And Taxes(95,402)(42,949)(25,306)
    Interest Expense -   -   -  
    Income Before Tax(95,402)(42,949)(25,306)
    Income Tax Expense48   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(95,450)(42,949)(25,306)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (95,450) (42,949) (25,306)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (95,450) (42,949) (25,306)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.